浙江医药 (600216.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(浙江医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 5,876,518,447.273,937,942,897.552,007,935,140.538,115,804,648.336,123,873,142.304,117,668,029.842,184,192,085.97
 营业利润(元) 259,254,227.97252,816,649.35105,302,495.52504,615,954.72501,545,377.47418,157,663.47268,017,651.01
 利润总额(元) 268,382,586.93262,915,098.18102,362,847.29491,388,420.68489,824,906.96410,163,375.33265,496,150.42
 净利润(元) 180,865,708.32187,000,510.5684,072,216.08362,613,741.95357,899,312.31312,305,494.63214,844,440.33
 归属于母公司股东的净利润(元) 301,338,595.24272,261,125.88113,551,849.15539,570,083.23484,454,300.43390,587,728.16260,543,171.58
盈利能力:
 销售毛利率(%) 33.5733.8433.7534.4735.7737.1337.80
 销售净利率(%) 3.084.754.194.475.847.589.84
 净资产收益率(%) 3.232.941.23----
 总资产报酬率ROA(%) 1.981.830.91----
 投入资本回报率ROIC(%) 2.952.651.125.454.903.952.64
营运能力:
 存货周转率(次) 1.961.230.67----
 应收账款周转率(次) 4.342.911.34----
 总资产周转率(次) 0.470.310.16----
偿债能力:
 资产负债率(%) 21.3920.8421.3121.9021.8925.4825.27
 股东权益比率(%) 75.5575.8675.3174.4874.0971.9371.93
 已获利息倍数(倍) -11.97-6.869.94-11.94-12.18-35.2615.13
 流动比率 2.142.282.262.292.522.022.10
 速动比率 1.331.421.411.451.571.221.36
发展能力:
 营业收入增长率(%) -4.04-4.36-8.07-11.10-10.10-10.83-8.99
 营业利润增长率(%) -48.31-39.54-60.71-57.22-42.42-28.65-12.99
 税后利润增长率(%) -37.80-30.29-56.42-48.38-35.46-23.06-2.37
 净资产增长率(%) 3.808.803.975.488.387.9613.77
 总资产增长率(%) 1.793.16-0.70-0.803.652.4214.80

前瞻产业研究院